Effect of Major Mycotoxins on Public Health Through the Consumption of Cheese Products.

IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL

Malaysian Journal of Medical Sciences Pub Date : 2024-12-01 Epub Date: 2024-12-31 DOI:10.21315/mjms2024.31.6.3

Elias Ath Chaidoutis, Olympia Chatzimpirou, Ioannis Migdanis, Athanasios Migdanis, Antonios Papadakis, Andreas Ch Lazaris, Nikolaos Kavantzas

{"title":"Effect of Major Mycotoxins on Public Health Through the Consumption of Cheese Products.","authors":"Elias Ath Chaidoutis, Olympia Chatzimpirou, Ioannis Migdanis, Athanasios Migdanis, Antonios Papadakis, Andreas Ch Lazaris, Nikolaos Kavantzas","doi":"10.21315/mjms2024.31.6.3","DOIUrl":null,"url":null,"abstract":"Food safety is a key priority for public health. However, consumer demand for cheese products may expose the population to the risk of mycotoxicosis and cancer, among others. Acute mycotoxicosis and cancer are examples of linked disorders. Among the most frequent toxic agents that enter the human body through food consumption are mycotoxins. This review study highlights the significance of the impact of the most important mycotoxins on public health through the consumption of cheese products. Despite being a poor substrate for mycotoxin development, cheese products have been found to contain harmful toxins. Aflatoxin M1 (AFM1) and ochratoxin A (OTA) are the main mycotoxins in cheese products, and they are very harmful to human health. Adherence to legislative limits and the implementation of appropriate control measures by food business operators (FBOs) are considered necessary to protect consumers' health.","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 6","pages":"21-33"},"PeriodicalIF":1.1000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740815/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21315/mjms2024.31.6.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Food safety is a key priority for public health. However, consumer demand for cheese products may expose the population to the risk of mycotoxicosis and cancer, among others. Acute mycotoxicosis and cancer are examples of linked disorders. Among the most frequent toxic agents that enter the human body through food consumption are mycotoxins. This review study highlights the significance of the impact of the most important mycotoxins on public health through the consumption of cheese products. Despite being a poor substrate for mycotoxin development, cheese products have been found to contain harmful toxins. Aflatoxin M₁ (AFM₁) and ochratoxin A (OTA) are the main mycotoxins in cheese products, and they are very harmful to human health. Adherence to legislative limits and the implementation of appropriate control measures by food business operators (FBOs) are considered necessary to protect consumers' health.

查看原文本刊更多论文

主要真菌毒素通过食用奶酪制品对公众健康的影响。

食品安全是公共卫生的一个关键优先事项。然而，消费者对奶酪产品的需求可能会使人群面临真菌中毒和癌症等风险。急性真菌中毒和癌症是相关疾病的例子。通过食物进入人体的最常见的毒物是真菌毒素。这项综述研究强调了最重要的真菌毒素通过食用奶酪产品对公众健康产生影响的重要性。尽管作为霉菌毒素发展的不良底物，奶酪产品已被发现含有有害毒素。黄曲霉毒素M1 （AFM1）和赭曲霉毒素A （OTA）是奶酪制品中的主要真菌毒素，对人体健康危害极大。食品经营者遵守立法限制和实施适当的控制措施被认为是保护消费者健康的必要条件。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Malaysian Journal of Medical Sciences MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

2.70

自引率

0.00%

发文量

审稿时长

9 weeks

期刊介绍： The Malaysian Journal of Medical Sciences (MJMS) is a peer-reviewed, open-access, fully online journal that is published at least six times a year. The journal’s scope encompasses all aspects of medical sciences including biomedical, allied health, clinical and social sciences. We accept high quality papers from basic to translational research especially from low & middle income countries, as classified by the United Nations & World Bank (https://datahelpdesk.worldbank.org/knowledgebase/ articles/906519), with the aim that published research will benefit back the bottom billion population from these countries. Manuscripts submitted from developed or high income countries to MJMS must contain data and information that will benefit the socio-health and bio-medical sciences of these low and middle income countries. The MJMS editorial board consists of internationally regarded clinicians and scientists from low and middle income countries.